ARTELUMEX FORTE

This brand name is authorized in Nigeria.

Active ingredients

The drug ARTELUMEX FORTE contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII C7D6T3H22J - ARTEMETHER
 

Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
 
Read more about Artemether
2
UNII F38R0JR742 - LUMEFANTRINE
 
Read more about Lumefantrine

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
B4-6184 Tablet ARTELUMEX 20/120 TABLETS TAB 20 mg; 120 mg 10X1X24 49 RNW-PP-339052 ARTELUMEX 20/120 TABLETS ARTEMETHER 20MG, LUMEFANTRINE 120MD Artemether 20mg, Lumefantrine 120mg, Croscarmellose Sodium BP, Hydroxypropylmethylcellulose USP (Methocel E5 Premium), Polysorbate 80 BP (Silvosorb 8020), Isopropyl Alcohol BP, Purified Water BP, Microcrystalline Cellulose BP (PH 112), Colloidal Anhydrous Silica BP, Purified Talc BP, Magnesium Stearate BP, IC-MS-218 IH, Methylene Chloride, Wincoat Ready mix, WT-1875 Yellow B4-6184 Drugs Imported Products 10X1X24 OTC 7/6/2023 ADLER PRODUCTS LTD, 32, Oduyemi Street,, Ikeja MEDIBIOS LABORATORIES LTD, J-76, MIDC, TARAPUR, BOISAR, PALGHAR, DIST.: THANE – 401 506, MAHARASHTRA, INDIA , India 27/03/2024
B4-6185 Tablet Artelumex-Forte Tablets TAB 80 mg; 480 mg 29/03/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
P01BF01 Artemether and lumefantrine P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations
Discover more medicines within P01BF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database B4-6184, B4-6185

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈